This week we continued to see big financings for mobile technology firms, and acquisitions in the software, cleantech, and life science spaces.
—Movik Networks, a Littleton, MA-based maker of products for helping mobile devices more speedily load Internet content, raised $25 million in a Series C financing. The round was led by new investor Oak Investment Partners, and included return backers Highland Capital Partners and North Bridge Venture Partners. I caught up with Movik CEO John St. Amand to find out how Movik will use the money to reach mobile carriers.
—Worcester, MA-based RXi Pharmaceuticals, a developer of RNA interference therapies, bought Apthera, a developer of peptide immunotherapies for cancer. Apthera shareholders will get 4.8 million shares of RXi, valued at $1.5o apiece before the announcement.
—OfficeDrop, a Cambridge, MA-based startup developing digital filing and scanning software to connect with cloud storage applications, raised $1 million in an angel financing led by New York-based White Owl Capital.
—North Andover, MA-based Nexamp, a firm that helps clients design and develop clean energy projects, said it acquired renewable energy services firm SolVera Energy of Hingham, MA, for an undisclosed sum.
—Jumptap, a Cambridge-based maker of mobile advertising software, raised $20 million of an equity round that could hit almost $28 million, an SEC filing showed. The investors of the funding round weren’t disclosed. Last year Jumptap, founded in 2004, landed a partnership deal with the Japanese firm Cyber Communications (CCI) that included an unspecified strategic investment from CCI.
—Waltham, MA-based health IT firm Forerun raised $2 million in a Series C deal led by the Massachusetts Technology Development Corporation. And a new startup focused on online skills tests, Smarterer, raised $1.25 million from True Ventures, and angel investors Dharmesh Shah, Joe Caruso, and Shikhar Ghosh.
—Israel-based business news website Globes reported that Boston Scientific, the Natick, MA medical devices maker, paid $5.13 million in cash last November when it bought S.I. Therapies, a make of a catheter device for treating artery blockages. Boston Scientific (NASDAQ: BSX) could pay a total of $24.3 million if S.I. hits certain milestones.
—Txteagle, a Boston- and San Francisco-based developer of a platform for mobile messaging in developing markets, snapped up $8.5 million in Series A financing led by Spark Capital in Boston. Txteagle’s existing seed investors—Flywheel Ventures, RBC Venture Partners, Qualcomm Ventures, and New York angel investor Esther Dyson—also participated in the new deal.